Bluestem Group Inc. provided earnings guidance for year ending February 3, 2017. For the year, the company expected adjusted EBITDA to be in the range of $85 million to $95 million, compared to the previous guidance of $130 million to $140 million and net sales to be in the range of $2.06 billion to 2.08 billion compared to the previous guidance of $2.06 billion to $2.15 billion.